SUMO2 and nasopharyngeal carcinoma: Furthermore, Western Blot (WB) experiments revealed that SUMO2 overexpression could downregulate and promote the ubiquitination degradation of Glucose Transporter 1 (GLUT1), thus inhibiting the glycolysis of NPC cells.